159 related articles for article (PubMed ID: 8242636)
1. Allelic deletions in renal tumors: histopathological correlations.
Presti JC; Reuter VE; Cordon-Cardo C; Mazumdar M; Fair WR; Jhanwar SC
Cancer Res; 1993 Dec; 53(23):5780-3. PubMed ID: 8242636
[TBL] [Abstract][Full Text] [Related]
2. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
3. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
[TBL] [Abstract][Full Text] [Related]
4. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000
[TBL] [Abstract][Full Text] [Related]
5. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
6. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
7. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
[TBL] [Abstract][Full Text] [Related]
8. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular characterization of human renal cell carcinoma cell lines.
Anglard P; Trahan E; Liu S; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
Cancer Res; 1992 Jan; 52(2):348-56. PubMed ID: 1345811
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
11. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study.
Hughson MD; Johnson LD; Silva FG; Kovacs G
Mod Pathol; 1993 Jul; 6(4):449-56. PubMed ID: 8415591
[TBL] [Abstract][Full Text] [Related]
12. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
15. Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: a breakpoint cluster between loci D3S1285 and D3S1603.
Wilhelm M; Bugert P; Kenck C; Staehler G; Kovacs G
Cancer Res; 1995 Nov; 55(22):5383-5. PubMed ID: 7585605
[TBL] [Abstract][Full Text] [Related]
16. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis.
van den Berg A; Hulsbeek MF; de Jong D; Kok K; Veldhuis PM; Roche J; Buys CH
Genes Chromosomes Cancer; 1996 Jan; 15(1):64-72. PubMed ID: 8824727
[TBL] [Abstract][Full Text] [Related]
17. Deletion mapping in human renal cell carcinoma.
Bergerheim U; Nordenskjöld M; Collins VP
Cancer Res; 1989 Mar; 49(6):1390-6. PubMed ID: 2924296
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754
[TBL] [Abstract][Full Text] [Related]
19. Precancerous lesions in the kidney.
Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
